Literature DB >> 10548442

Changes in methadone treatment practices: results from a panel study, 1988-1995.

T D'Aunno1, N Folz-Murphy, X Lin.   

Abstract

Results from several studies conducted in the late 1980s and early 1990s showed that the majority of the nation's methadone treatment units did not use effective treatment practices. Since then, however, many efforts have been made to improve critical treatment practices. This paper examines the extent to which key methadone treatment practices (dose levels, treatment duration, client influence in dose decisions) changed from 1988 to 1995 in a panel sample of methadone maintenance units. We also examine factors that may account for variation in methadone treatment practices. We use panel data from a national random sample of 172 units in 1988 (82% response rate), 140 units in 1990 (87% response rate), and 116 units in 1995 (89% response rate). Unit directors and clinical supervisors provided phone survey data on clients influence on doses, upper limits on doses, average dose levels, unit emphasis on decreasing doses, time when clients are encouraged to detoxify, and average length of treatment. Results from random effects regression analyses indicate that treatment practices concerning methadone dose levels, client influence in dose decisions, and treatment duration improved significantly between 1988 and 1995. Several characteristics of clients (race, age) and treatment units (staff, ownership, geographic location) are associated with the use of less-effective treatment practices. Efforts to improve treatment practices appear to be making progress and certainly need to be continued.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548442     DOI: 10.1081/ada-100101886

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  14 in total

1.  Beliefs about methadone in an inner-city methadone clinic.

Authors:  Sharon Stancliff; Julie Elana Myers; Stuart Steiner; Ernest Drucker
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

Review 2.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Using Acceptance and Commitment Therapy during Methadone Dose Reduction: Rationale, Treatment Description, and a Case Report.

Authors:  Angela L Stotts; Akihiko Masuda; Kelly Wilson
Journal:  Cogn Behav Pract       Date:  2009-05-01

4.  Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs.

Authors:  Christina M Andrews; Thomas A D'Aunno; Harold A Pollack; Peter D Friedmann
Journal:  Med Care Res Rev       Date:  2013-09-18       Impact factor: 3.929

5.  Increases in body mass index following initiation of methadone treatment.

Authors:  Jennifer M Fenn; Jennifer S Laurent; Stacey C Sigmon
Journal:  J Subst Abuse Treat       Date:  2014-11-05

6.  Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.

Authors:  Ping Liu; Grover Foster; Robert Labadie; Eugene Somoza; Amarnath Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Dosage patterns in methadone treatment: results from a national survey, 1988-2005.

Authors:  Harold A Pollack; Thomas D'Aunno
Journal:  Health Serv Res       Date:  2008-06-03       Impact factor: 3.402

8.  Organizational determinants of outpatient substance abuse treatment duration in women.

Authors:  Cynthia I Campbell; Jeffrey A Alexander; Christy Harris Lemak
Journal:  J Subst Abuse Treat       Date:  2008-11-26

9.  Treatment practice and research issues in improving opioid treatment outcomes.

Authors:  T Ron Jackson
Journal:  Sci Pract Perspect       Date:  2002-07

10.  Methadone treatment at forty.

Authors:  Ira J Marion
Journal:  Sci Pract Perspect       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.